Express News | Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersFeb 10 19:00 ET

Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $63

Moomoo NewsFeb 7 16:32 ET · Ratings

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Is Expected To Breakeven In The Near Future

Simply Wall StFeb 1 09:58 ET

Insider Sale: CHIEF MEDICAL OFFICER of $MIRM (MIRM) Sells 6,969 Shares

Quiver QuantitativeJan 21 16:31 ET

Mirum Pharmaceuticals Insider Sold Shares Worth $319,598, According to a Recent SEC Filing

MT NewswiresJan 21 16:28 ET

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Zacks Jan 16 11:35 ET